Raymond James & Associates’s Invesco Bloomberg Analyst Rating Improvers ETF UPGD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $4.35M | Sell |
60,488
-3,633
| -6% | -$249K | ﹤0.01% | 1749 |
|
|
2024
Q2 | $4.2M | Sell |
64,121
-2,832
| -4% | -$184K | ﹤0.01% | 1706 |
|
|
2024
Q1 | $4.43M | Sell |
66,953
-34,119
| -34% | -$2.15M | ﹤0.01% | 1677 |
|
|
2023
Q4 | $6.25M | Sell |
101,072
-12,188
| -11% | -$685K | ﹤0.01% | 1387 |
|
|
2023
Q3 | $6.31M | Sell |
113,260
-51,268
| -31% | -$2.99M | 0.01% | 1315 |
|
|
2023
Q2 | $9.57M | Buy |
164,528
+910
| +0.6% | +$50.3K | 0.01% | 1070 |
|
|
2023
Q1 | $9.06M | Buy |
163,618
+6,124
| +4% | +$351K | 0.01% | 1085 |
|
|
2022
Q4 | $8.53M | Sell |
157,494
-756
| -0.5% | -$41K | 0.01% | 1078 |
|
|
2022
Q3 | $8.02M | Buy |
158,250
+51,209
| +48% | +$2.85M | 0.01% | 1079 |
|
|
2022
Q2 | $5.47M | Buy |
107,041
+7,344
| +7% | +$410K | 0.01% | 1343 |
|
|
2022
Q1 | $6.09M | Sell |
99,697
-2,933
| -3% | -$176K | 0.01% | 1369 |
|
|
2021
Q4 | $6.45M | Buy |
102,630
+4,641
| +5% | +$291K | 0.01% | 1376 |
|
|
2021
Q3 | $5.88M | Sell |
97,989
-372
| -0.4% | -$22.2K | 0.01% | 1393 |
|
|
2021
Q2 | $6.05M | Sell |
98,361
-30,114
| -23% | -$1.82M | 0.01% | 1362 |
|
|
2021
Q1 | $7.43M | Sell |
128,475
-6,183
| -5% | -$345K | 0.01% | 1199 |
|
|
2020
Q4 | $6.86M | Sell |
134,658
-20,764
| -13% | -$954K | 0.01% | 1159 |
|
|
2020
Q3 | $6.19M | Sell |
155,422
-16,963
| -10% | -$680K | 0.01% | 1112 |
|
|
2020
Q2 | $6.73M | Sell |
172,385
-11,779
| -6% | -$409K | 0.01% | 1026 |
|
|
2020
Q1 | $5.28M | Sell |
184,164
-63,303
| -26% | -$2.62M | 0.01% | 1021 |
|
|
2019
Q4 | $11.9M | Sell |
247,467
-69,323
| -22% | -$3.08M | 0.02% | 816 |
|
|
2019
Q3 | $13.5M | Sell |
316,790
-68,199
| -18% | -$2.93M | 0.02% | 723 |
|
|
2019
Q2 | $17.3M | Buy |
384,989
+10,977
| +3% | +$484K | 0.02% | 591 |
|
|
2019
Q1 | $16.4M | Sell |
374,012
-20,866
| -5% | -$878K | 0.02% | 592 |
|
|
2018
Q4 | $14.4M | Sell |
394,878
-45,907
| -10% | -$1.96M | 0.03% | 594 |
|
|
2018
Q3 | $21.4M | Buy |
440,785
+54,650
| +14% | +$2.63M | 0.03% | 506 |
|
|
2018
Q2 | $18.1M | Buy |
386,135
+21,726
| +6% | +$998K | 0.03% | 545 |
|
|
2018
Q1 | $15.8M | Sell |
364,409
-22,488
| -6% | -$996K | 0.03% | 562 |
|
|
2017
Q4 | $16.8M | Buy |
386,897
+25,389
| +7% | +$1.06M | 0.03% | 534 |
|
|
2017
Q3 | $15M | Buy |
361,508
+5,274
| +1% | +$210K | 0.03% | 558 |
|
|
2017
Q2 | $14.4M | Sell |
356,234
-19,776
| -5% | -$786K | 0.03% | 554 |
|
|
2017
Q1 | $15.1M | Buy |
376,010
+13,438
| +4% | +$530K | 0.04% | 507 |
|
|
2016
Q4 | $13.9M | Buy |
362,572
+15,333
| +4% | +$571K | 0.04% | 491 |
|
|
2016
Q3 | $12.7M | Buy |
347,239
+37,203
| +12% | +$1.32M | 0.03% | 504 |
|
|
2016
Q2 | $10.3M | Sell |
310,036
-14,833
| -5% | -$489K | 0.03% | 527 |
|
|
2016
Q1 | $10.6M | Sell |
324,869
-80,576
| -20% | -$2.43M | 0.04% | 508 |
|
|
2015
Q4 | $13.2M | Sell |
405,445
-162,214
| -29% | -$5.46M | 0.05% | 419 |
|
|
2015
Q3 | $18.3M | Sell |
567,659
-114,960
| -17% | -$4.01M | 0.07% | 285 |
|
|
2015
Q2 | $25M | Buy |
682,619
+41,223
| +6% | +$1.53M | 0.1% | 237 |
|
|
2015
Q1 | $23.5M | Sell |
641,396
-13,974
| -2% | -$491K | 0.1% | 213 |
|
|
2014
Q4 | $22.9M | Sell |
655,370
-15,772
| -2% | -$535K | 0.11% | 190 |
|
|
2014
Q3 | $22.7M | Buy |
671,142
+81,672
| +14% | +$2.83M | 0.13% | 161 |
|
|
2014
Q2 | $20.8M | Sell |
589,470
-17,804
| -3% | -$602K | 0.13% | 174 |
|
|
2014
Q1 | $20.9M | Buy |
607,274
+170,672
| +39% | +$5.74M | 0.14% | 151 |
|
|
2013
Q4 | $14.6M | Buy |
436,602
+160,301
| +58% | +$5.11M | 0.11% | 200 |
|
|
2013
Q3 | $8.48M | Buy |
276,301
+106,358
| +63% | +$3.17M | 0.07% | 310 |
|
|
2013
Q2 | $4.81M | Buy |
+169,943
| New | +$4.61M | 0.05% | 444 |
|
Other funds holding UPGD
RJFSA
TRCT
OFG
HSA
MWM
Raymond James & Associates's UPGD Position: Q3 2024 in Review
Raymond James & Associates reduced its Invesco Bloomberg Analyst Rating Improvers ETF (UPGD) stake by 5.7% in Q3 2024, selling an estimated $249K and leaving 60,488 shares worth $4.35M. The position accounts for ﹤0.01% of the portfolio, ranked #1749.
Raymond James & Associates first reported a position in UPGD in Q2 2013 and has held it in 46 quarters since. The position peaked at $25M in Q2 2015. 28 funds tracked by Wall St. Rank hold UPGD as of Q3 2024.
- Raymond James & Associates held 60,488 shares of Invesco Bloomberg Analyst Rating Improvers ETF worth $4.35M as of Q3 2024.
- Raymond James & Associates sold 3,633 Invesco Bloomberg Analyst Rating Improvers ETF shares in Q3 2024, an estimated $249K.
- Invesco Bloomberg Analyst Rating Improvers ETF made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1749 holding.
- Raymond James & Associates first reported a position in Invesco Bloomberg Analyst Rating Improvers ETF in Q2 2013 and has held it in 46 quarters since.
- Raymond James & Associates's Invesco Bloomberg Analyst Rating Improvers ETF position peaked at $25M in Q2 2015.
- 28 funds tracked by Wall St. Rank held Invesco Bloomberg Analyst Rating Improvers ETF as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.